发明名称 |
Pharmaceutical composition containing antagonists of growth factor of vascular endothelial cells |
摘要 |
<p>(A) A compsn. is claimed comprising a human vascular endothelial growth factor (hVEGF) antagonist, provided however that the antagonist is not the flt or flk-1 or KOR receptor or a neutralising anti-hVEGF antibody. Also claimed are: (B) a monoclonal antibody (MAb) amino acid sequence capable of specifically binding to a HVEGF receptor (hVEGFr) or a hVEGF-hVEGFr; (C) a polypeptide comprising an amino acid sequence comprising a bVEGFr and an immunoglobulin chain; (D) a method of treatment of a tumour in a mammal comprising administering a HVEGF antagonist to reduce the size of the tumour.</p> |
申请公布号 |
CZ291047(B6) |
申请公布日期 |
2002.12.11 |
申请号 |
CZ19950001057 |
申请日期 |
1992.10.28 |
申请人 |
GENENTECH, INC. |
发明人 |
FERRARA NAPOLEONE;KIM KYUNG JIN |
分类号 |
C12N15/09;A61K38/00;A61K38/17;A61K38/18;A61K39/395;A61P35/00;C07K14/71;C07K14/715;C07K16/22;C07K16/24;C07K16/28;C12N15/02;C12N15/13;C12P21/02;C12P21/08;(IPC1-7):A61K38/18 |
主分类号 |
C12N15/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|